Overview / Abstract: |
Target Audience Program Overview This program will utilize integrated case studies to illustrate the journey of a patient with PAH to facilitate early recognition and diagnosis. The program will provide guidance on updated approaches for diagnosis and distinguishing PAH from other disorders with similar presentations. Experts will clarify the utility of available and emerging therapies for PAH and provide recommendations to design patient-centered treatment plans and ensure patient satisfaction with treatment that will aim to improve quality of life. Learning Objectives Recognize the role for the NP to improve patient outcomes in PAH |
Expiration |
May 26, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, AANP |
Presenters / Authors / Faculty |
Vallerie V. McLaughlin, MD |
Sponsors / Supporters / Grant Providers |
Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Pulmonary Hypertension Free CE CME |